Mannitol Administration for Reducing Intracranial Pressure

Dosing and Administration

• Clinical guidelines recommend using mannitol at a dose of 250 mOsm, infused over 15-20 minutes 1, 2, 3

Efficacy and Clinical Indications

• Among therapies that decrease ICP, only mannitol has been associated with improved cerebral oxygenation 1, 2
• Mannitol should be administered when there are obvious neurological signs of increased ICP, such as pupillary abnormalities or neurological worsening not attributable to systemic causes 1, 2, 4
• Mannitol is the treatment of choice for signs of brain herniation 1, 2

Monitoring and Precautions

• Serum osmolality should be monitored to ensure it remains below 320 mOsm/L 4

Comparative Efficacy and Side Effects

• At equiosmotic doses, mannitol and hypertonic saline have comparable efficacy in treating intracranial hypertension 1, 2
• Mannitol induces osmotic diuresis and requires volume compensation 1, 2

Cerebral Perfusion Pressure Considerations

• While treating elevated ICP with mannitol, cerebral perfusion pressure should be maintained between 60-70 mmHg 1, 2, 3, 5

Mannitol Administration in Hypotension

Critical Hemodynamic Considerations

• Cerebral perfusion pressure (CPP) must be maintained between 60-70 mmHg during mannitol administration, particularly in patients with low CPP, as they have autoregulatory vasodilation that allows mannitol's vasoconstrictive mechanism to work effectively 6
• With a BP of 90/60 (MAP approximately 70 mmHg), if intracranial pressure is elevated, the CPP may already be critically low 6

Clinical Management Algorithm

• Initiate aggressive fluid resuscitation with crystalloids before or concurrent with mannitol administration, as hypotension is a critical secondary insult that must be addressed 7, 6
• Mannitol induces osmotic diuresis requiring volume compensation 7, 6

Alternative Consideration

• Hypertonic saline has comparable efficacy to mannitol at equiosmotic doses (250 mOsm) for reducing ICP, and is the superior choice over mannitol in the setting of hypotension or hypovolemia 7, 6

Management of Increased Intracranial Pressure in Neurotrauma

Primary Recommendations

• The American College of Anaesthesia recommends mannitol 20% or hypertonic saline at 250 mOsm infused over 15-20 minutes as first-line osmotic agents for managing increased intracranial pressure in neurotrauma, with glycerol not recommended as a first-line agent 8
• Mannitol 20% at 250 mOsm (0.25-1.0 g/kg) infused over 15-20 minutes is the guideline-recommended treatment for threatened intracranial hypertension or signs of brain herniation after controlling secondary brain insults 8

Cerebral Perfusion Pressure Targets

• The American College of Anaesthesia recommends maintaining cerebral perfusion pressure (CPP) between 60-70 mmHg during osmotic therapy, as CPP < 60 mmHg is associated with poor neurological outcome and CPP > 70 mmHg increases risk of respiratory distress syndrome without improving outcomes 8

Clinical Monitoring Requirements

• The American College of Anaesthesia recommends monitoring serum osmolality to ensure it remains below 320 mOsm/L, and monitoring for signs of cerebral edema or increased intracranial pressure when using osmotic agents 9, 10, 11
• ICP monitoring is indicated in patients with abnormal initial CT scan, GCS ≤8, and inability to perform neurological assessment, as well as post-operative monitoring after intracranial hematoma evacuation with certain clinical signs 8, 9, 10, 11

Management of Severe Traumatic Brain Injury

Initial Treatment and Monitoring

• The American College of Anaesthesiologists recommends avoiding aggressive hyperventilation (pCO2 <30 mmHg) as it causes cerebral vasoconstriction, reducing cerebral blood flow and potentially worsening ischemic injury, with a target PaCO2 of 4.5-5.0 kPa (34-38 mmHg) 12, 13
• In cases of acute herniation, temporary mild hyperventilation may be used only as a bridge to definitive therapy, emphasizing the importance of maintaining normocapnia to mild hypocapnia 12, 13
• The Brain Trauma Foundation suggests that imaging is essential for definitive diagnosis and surgical planning, and the patient should proceed to CT scan expeditiously after stabilization 14

Blood Pressure Thresholds for Mannitol Administration

Clinical Management Algorithm

• The American Heart Association recommends monitoring and maintaining systolic blood pressure at or above baseline where the patient is asymptomatic, and avoiding systolic blood pressure >180 mmHg 15
• In perioperative moyamoya disease, mannitol should be avoided entirely, and systolic blood pressure goal should be set at or above preoperative baseline, with patients kept euvolemic to mildly hypervolemic to avoid hypotension and decreased cerebral perfusion pressure 15

Specific Clinical Contexts

• The American Stroke Association recommends that in perioperative moyamoya disease, mannitol should be avoided entirely 15